Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Jun;100(2):301–304. doi: 10.1111/j.1476-5381.1990.tb15799.x

On the blockade of acetylcholine release at mouse motor nerve terminals by beta-bungarotoxin and crotoxin.

E G Rowan 1, K E Pemberton 1, A L Harvey 1
PMCID: PMC1917425  PMID: 2116202

Abstract

1. beta-Bungarotoxin and crotoxin are phospholipose A2 neurotoxins, which block irreversibly the evoked release of acetylcholine from motor nerve terminals of mouse triangularis sterni preparations. 2. Extracellular recording of nerve terminal action potentials reveal that inhibition of transmitter release is not associated with failure of the action potential to invade nerve terminals. 3. When evoked transmitter release (measured as intracellularly recorded endplate potentials) was blocked by beta-bungarotoxin, spontaneous acetylcholine release was stimulated as in control experiments by K(+)-induced depolarization and by the Ca2(+)-ionophore A23187. 4. The site of action of the toxins remains to be elucidated but would appear to be associated with the coupling of action potential induced-depolarization to the release mechanism, rather than with the release mechanism itself.

Full text

PDF
301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe T., Limbrick A. R., Miledi R. Acute muscle denervation induced by beta-bungarotoxin. Proc R Soc Lond B Biol Sci. 1976 Nov 12;194(1117):545–553. doi: 10.1098/rspb.1976.0093. [DOI] [PubMed] [Google Scholar]
  2. Anderson A. J., Harvey A. L. Omega-conotoxin does not block the verapamil-sensitive calcium channels at mouse motor nerve terminals. Neurosci Lett. 1987 Nov 23;82(2):177–180. doi: 10.1016/0304-3940(87)90125-x. [DOI] [PubMed] [Google Scholar]
  3. Anderson A. J., Harvey A. L., Rowan E. G., Strong P. N. Effects of charybdotoxin, a blocker of Ca2+-activated K+ channels, on motor nerve terminals. Br J Pharmacol. 1988 Dec;95(4):1329–1335. doi: 10.1111/j.1476-5381.1988.tb11772.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Breithaupt H. Neurotoxic and myotoxic effects of crotalus phospholipase A and its complex with crotapotin. Naunyn Schmiedebergs Arch Pharmacol. 1976;292(3):271–278. doi: 10.1007/BF00517389. [DOI] [PubMed] [Google Scholar]
  5. Chang C. C., Chen T. F., Lee C. Y. Studies of the presynaptic effect of -bungarotoxin on neuromuscular transmission. J Pharmacol Exp Ther. 1973 Feb;184(2):339–345. [PubMed] [Google Scholar]
  6. Chang C. C., Lee J. D. Crotoxin, the neurotoxin of South American rattlesnake venom, is a presynaptic toxin acting like beta-bungarotoxin. Naunyn Schmiedebergs Arch Pharmacol. 1977 Jan;296(2):159–168. doi: 10.1007/BF00508469. [DOI] [PubMed] [Google Scholar]
  7. Chang C. C. Neurotoxins with phospholipase A2 activity in snake venoms. Proc Natl Sci Counc Repub China B. 1985 Apr;9(2):126–142. [PubMed] [Google Scholar]
  8. Harris J. B. Phospholipases in snake venoms and their effects on nerve and muscle. Pharmacol Ther. 1985;31(1-2):79–102. doi: 10.1016/0163-7258(85)90038-5. [DOI] [PubMed] [Google Scholar]
  9. Hawgood B. J., Smith J. W. The mode of action at the mouse neuromuscular junction of the phospholipase A-crotapotin complex isolated from venom of the South American rattlesnake. Br J Pharmacol. 1977 Dec;61(4):597–606. doi: 10.1111/j.1476-5381.1977.tb07553.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hong S. J., Chang C. C. Use of geographutoxin II (mu-conotoxin) for the study of neuromuscular transmission in mouse. Br J Pharmacol. 1989 Jul;97(3):934–940. doi: 10.1111/j.1476-5381.1989.tb12034.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kamenskaia M. N., Satybaldina N. K. Deistvie presinapticheskogo neíroktoksina notekhisa II-5 iz iada tigrovoi zmei na dvigatel'nye nervnye okonchaniia myshi. Biull Eksp Biol Med. 1979 Oct;88(10):417–419. [PubMed] [Google Scholar]
  12. Mallart A. Electric current flow inside perineurial sheaths of mouse motor nerves. J Physiol. 1985 Nov;368:565–575. doi: 10.1113/jphysiol.1985.sp015876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nowycky M. C., Fox A. P., Tsien R. W. Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature. 1985 Aug 1;316(6027):440–443. doi: 10.1038/316440a0. [DOI] [PubMed] [Google Scholar]
  14. Oberg S. G., Kelly R. B. The mechanism of beta-bungarotoxin action. I. Modification of transmitter release at the neuromuscular junction. J Neurobiol. 1976 Mar;7(2):129–141. doi: 10.1002/neu.480070206. [DOI] [PubMed] [Google Scholar]
  15. Penner R., Dreyer F. Two different presynaptic calcium currents in mouse motor nerve terminals. Pflugers Arch. 1986 Feb;406(2):190–197. doi: 10.1007/BF00586682. [DOI] [PubMed] [Google Scholar]
  16. Rowan E. G., Harvey A. L. Potassium channel blocking actions of beta-bungarotoxin and related toxins on mouse and frog motor nerve terminals. Br J Pharmacol. 1988 Jul;94(3):839–847. doi: 10.1111/j.1476-5381.1988.tb11595.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES